We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.
Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10th Annual SCOPE Summit on Feb 19.
While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.
What is most rewarding to you as you consider your contribution to clinical trial research?
The ability to help advance science and treat disease.
How do you define patient engagement? What does that term mean to you?
BBK Worldwide is very excited to be participating in the Cambridge Health Institute’s 7th Annual SCOPE Summit for Clinical Ops Executives. Taking place February 23 – 25 in Miami FL, SCOPE will offer three days of in-depth discussions addressing the operational, technological and data-related aspects of clinical trial planning and management, with 12 different conferences, 4 pre-conference workshops and 2 symposia.
In earlier posts we have explored how mHealth can increase both patient engagement and site engagement. Today’s blog comes from Jason Rightmyer, Director of Research Informatics with the Institute of Aging Research (a Harvard Medical School Affiliate) who explores how mobile health technology is attributing to physician engagement. Thanks for contributing!
According to industry estimates reported by research2guidance, 500 million smartphone users worldwide will be using a healthcare app this year, and by 2018, 50 percent of the more than 3.4 billion smartphone and tablet users will have downloaded at least one mobile health app. While patient engagement is key to the overall success of the mHealth movement, the vital role physician engagement plays must not be overlooked.
Underscoring its Commitment to Patient Advocacy and Care, My Clinical Study BuddySM Mobile Apps to Help Boost Patient Engagement
Mobile Apps to Streamline Valuable Resource and Information Sharing, Better Connect Advocacy Groups, Pharmaceutical Sponsors and Patients
DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 16, 2014--BBK Worldwide, a leading clinical trial marketing firm, today unveiled two new mobile apps for patient and site engagement, My Clinical Study BuddySM and My Clinical Study BuddySM Protocol Pointers Edition. Available for Apple® and Android™ mobile phones and tablets, both apps are available today on iTunes® and the Google Play™ store and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.
Customized Apple® iPad AirTM Enhances Doctor-Patient Interactions in Clinical Trials
Patient screening and enrollment has traditionally required a deluge of paper-checklist-type items. We all know them: chart flags, contingency plans, I / E cards, panel mining guides, other prescreening tools, and of course, the protocol. And the more protocols a trial involves, the more trees we have to kill, right?
Enrollment goals – every site has them. As the study sponsor, you’ve made your projections and communicated your expectations to each principal investigator. They have all assured you that they’ll have no trouble meeting your goals. Perhaps even a few of them told you they can enroll more than your goal. No problem, right?
2012 was a busy year for the BBK Worldwide team. New products were introduced, a few awards were won, and a new online shopping experience for the latest clinical R&D tools and technology was created. As the year winds down, we thought we’d share with you our top five most popular patient recruitment products sold on our online store.